Clinical trial

CSTC1 for Diabetic Foot Ulcers Phase II Study

NCT01813305

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-09

PhasePHASE2

Study timeline

Study start (actual)2014-07-09Date precision: day

Registry last updated2022-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcerunresolved

Diabetes Mellitusunresolved

Woundsunresolved

Interventions

CSTC1DRUG

CSTC1 Matched vehicleDRUG

Sponsors & collaborators

Charsire Biotechnology Corp.lead sponsor

ASKLEP Inc.collaborator

Mapped research locations

Kaohsiung CityTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01813305 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.